India to Brazil: Gliclazide Export Trade Route
India has recorded 591 verified shipments of Gliclazide exported to Brazil, representing a combined trade value of $20.7M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $35.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 37% of total export value with 219 shipments worth $7.7M USD. On the buying side, TORRENT DO BRASIL LTDA is the largest importer in Brazil with $3.7M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Gliclazide corridor is one of India's established pharmaceutical export routes, with 591 shipments documented worth a combined $20.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $35.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with gliclazide's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #3 among India's top gliclazide export destinations globally.
On the import side, key buyers of Indian gliclazide in Brazil include TORRENT DO BRASIL LTDA, TORRENT DO BRASIL LTDA , RANBAXY FARMACEUTICA LTDA : and 26 others. TORRENT DO BRASIL LTDA is the single largest importer with 144 shipments valued at $3.7M USD.
